Monday, July 1, 2024

Participants in Clinical Trials on Chronic Back or Neck Pain Are Not Representative of the Larger Patient Population

Populations that experience health disparities are frequently underrepresented in spine pain clinical trials

Click here to view in browser.

U.S. Department of Health & Human Services  /  National Institutes of Health

Populations that experience health disparities are frequently underrepresented in spine pain clinical trials, according to an analysis of data from eight randomized controlled trials (RCTs) of spinal manipulation for chronic back or neck pain. Funded by the National Center for Complementary and Integrative Health, this analysis was conducted by researchers from the University of Minnesota and North Dakota State University and was published in the journal BMC Musculoskeletal Disorders.

RCTs are regarded as the gold standard study design for evaluating treatment effectiveness, involving random assignment of participants to different groups to minimize bias and assess intervention impact. However, studies of this type are sometimes criticized for generalizability issues. For example, how well do the people participating in the trial represent the larger community of people receiving care in real-world settings? The generalizability of RCT populations is important because it potentially limits the applicability of RCT findings to influence clinical practice and policy.

Read the full Research Spotlight


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Center for Complementary and Integrative Health · 9000 Rockville Pike · Bethesda, MD 20892 GovDelivery logo

No comments:

Post a Comment

Why Long-Term Investors Should Eye TSLA's Robotaxi Potential

Tesla, Inc. (TSLA) is set to release its second-quarter delivery update in early July, which is expected to show a decline for the second ...